Track topics on Twitter Track topics that are important to you
BioLegend develops and manufactures world-class, cutting-edge immunological reagents for biomedical research, offered at an outstanding value. Our product areas include cell immunophenotyping, cytokines and chemokines, adhesion, cancer research, T regulatory cells, stem cells, innate immunity, cell-cycle analysis, apoptosis, and modification-specific antibodies. All of BioLegend’s reagents are supported by superior customer service and come with a quality guarantee. Our aggressive product development program, through technology licensing, collaborations, and internal hybridoma development, produces strategic reagents for use in a variety of applications including flow cytometry, ELISA, immunoprecipitation, Western blotting, immunofluorescence microscopy, immunohistochemistry, and in vitro or in vivo functional assays. BioLegend offers the broadest selection of fluorochrome conjugates for multi-color flow cytometry. With an experienced biochemistry team, BioLegend is well positioned to offer a wide range of custom conjugation services to meet our customers’ specific needs.
BioLegend was incorporated in June, 2002. The founder and CEO of BioLegend, Gene Lay, D.V.M., who was also the co-founder of PharMingen, has extensive background in the research reagent business. Brad Kraft, Vice President of Business Development & Global Marketing and President, BioLegend International Division, has been involved in the biotechnology community for over 20 years. In 1988, Brad joined PharMingen as co-founder in charge of Marketing, Business and Corporate Development. Brad subsequently worked with numerous emerging biotech companies in the areas of corporate/business development, global strategy and marketing. Dr. Nan Jiang, Vice President of Operations, has over 15 years extensive experience in organic chemistry and protein chemistry both in academia and industry. Dr. Jiang was formerly the Process Development Manager at PharMingen. Xifeng Yang, M.D., Vice President of Cellular Analysis, has over 17 years research and development experience in the fields of immunology, hematology, and cell biology. Previously, Dr. Yang was a scientist at PharMingen for over 6 years. Kent Johnson, Chief Financial Officer and Nancy Huang, Vice President of International Sales and Marketing, bring a vast amount of knowledge and experience in biotechnology to BioLegend, each with over 10 years tenure with PharMingen.
Additionally, BioLegend has a staff of highly experienced scientific and technical professionals who have extensive experience in the industry. BioLegend strives to provide quality research reagents and expert technical support to the scientific community worldwide. BioLegend is located in San Diego, in the midst of one of the nation’s largest and fastest growing biotechnology areas. As a result of the company’s rapid growth, BioLegend has expanded its operations and moved to a new facility in Sorrento West Life Science Park , San Diego, in January 2007. Our close proximity to world-renowned research institutions, such as The Scripps Research Institute, the Salk Institute, The Burnham Institute, and University of California – San Diego, catalyzes scientific exchange and collaborations.
BioLegend Japan KK, in partnership with Tomy Digital Biology Co., Ltd., opened in Tokyo in February 2008. Yoshiro Namai, President, BioLegend Japan KK, and Yoko Yano, Marketing and Business Development Manager, lead a highly experienced and trained technical staff, providing immediate access to BioLegend’s entire portfolio of reagents and the highest level of customer service and technical support.
We look forward to serving your research needs and becoming your long term research partner. We welcome your feedback and suggestions to better serve the research community at large.
11080 Roselle Street
United States of America
Chromatrap® announces that BioLegend, a major US-based manufacturer and supplier of reagents and kits for biomedical research, has chosen their novel solid-state ChIP technology to power a new range ...
Chromatrap® announces that BioLegend, a major US-based manufacturer and supplier of reagents and kits for biomedical research, has chosen their novel solid-state ChIP technology to power a new ran...
Quicker Western Blots with Direct-Blot Antibodies
BioLegend develops and manufactures world-class, cutting-edge antibodies and reagents at an outstanding value to customers for biomedical research. The broad product portfolio inc...
BioLegend develops and manufactures world-class, cutting-edge immunological reagents for biomedical research, offered at an outstanding value. Our product areas include cell immunophenotyping, cytokin...
We have published hundreds of BioLegend news stories on BioPortfolio along with dozens of BioLegend Clinical Trials and PubMed Articles about BioLegend for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BioLegend Companies in our database. You can also find out about relevant BioLegend Drugs and Medications on this site too.
Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...